BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Harvard Business School
US Department of Justice
McKesson
Moodys
Chubb
Fuji
Daiichi Sankyo
Julphar

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,736,541

« Back to Dashboard

Summary for Patent: 5,736,541
Title: Olanzapine polymorph crystal form
Abstract:The invention provides Form II, a pharmaceutically elegant, stable polymorph of olanzapine useful for treating a condition selected from the group consisting of a psychotic condition, mild anxiety and gastrointestinal conditions.
Inventor(s): Bunnell; Charles Arthur (Lafayette, IN), Hendriksen; Barry Arnold (Guildford, GB), Larsen; Samuel Dean (West Lafayette, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN) Eli Lilly and Company (Basingstoke, GB2)
Application Number:08/686,989
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form; Process; Use;

Drugs Protected by US Patent 5,736,541

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,736,541

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece 3035355 ➤ Subscribe
United Kingdom 2313835 ➤ Subscribe
Germany 69636313 ➤ Subscribe
Germany 69630324 ➤ Subscribe
Germany 69614426 ➤ Subscribe
Germany 69611003 ➤ Subscribe
Denmark 1095941 ➤ Subscribe
Denmark 1445259 ➤ Subscribe
Eurasian Patent Organization 000149 ➤ Subscribe
Estonia 9700232 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Healthtrust
Medtronic
Chubb
Teva
Queensland Health
Cantor Fitzgerald
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot